# Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients

> **NCT03576638** · PHASE2 · UNKNOWN · sponsor: **Intec Pharma Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Accordion Pill Carbidopa/Levodopa
- **DRUG:** Sinemet CR 25Mg-100Mg Extended-Release Tablet

## Key facts

- **NCT ID:** NCT03576638
- **Lead sponsor:** Intec Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576638, "Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03576638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*